1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
- Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
- Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study
- The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers into breast cancer clinical trials and daily practice
- 2019
- Analytical validation of a standardized scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicenter collaboration
- The circular RNome of primary breast cancer
- 2018
- Abstract P2-03-01: Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration
- 2017
- Societal challenges of precision medicine : Bringing order to chaos
- 2016
-
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration
Smid, Marcel ; Rodríguez-González, F Germán ; Sieuwerts, Anieta M ; Salgado, Roberto ; Prager-Van der Smissen, Wendy J C ; Vlugt-Daane, Michelle van der ; van Galen, Anne ; Nik-Zainal, Serena ; Staaf, Johan LU
and Brinkman, Arie B
, et al.
(2016)
In Nature Communications
7.
Mark
- 2015
- An international study to increase concordance in Ki67 scoring.